SS
VSTM icon

Steve Schonfeld’s Verastem VSTM Stock Holding History

Steve Schonfeld’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-36,180
Closed -$187K – 2513
2024
Q4 		$187K Buy
+36,180
New +$142K ﹤0.01% 1770
2019
Q3 		– Sell
-2,275
Closed -$41K – 1261
2019
Q2 		$41K Buy
+2,275
New +$51.5K ﹤0.01% 945
2019
Q1 		– Sell
-9,452
Closed -$381K – 1309
2018
Q4 		$381K Buy
+9,452
New +$577K 0.01% 744

Other funds holding VSTM

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Steve Schonfeld's VSTM Position: Q1 2025 in Review

Steve Schonfeld sold out of Verastem (VSTM) in Q1 2025, closing a stake of 36,180 shares — an estimated $187K sold.

Steve Schonfeld first reported a position in VSTM in Q4 2018 and held it in 3 quarters. The position peaked at $381K in Q4 2018. 100 funds tracked by Wall St. Rank hold VSTM as of Q1 2025.

  • Steve Schonfeld reported no remaining Verastem position as of Q1 2025 after selling out during the quarter.
  • Steve Schonfeld sold 36,180 Verastem shares in Q1 2025, an estimated $187K.
  • Steve Schonfeld first reported a position in Verastem in Q4 2018 and held it in 3 quarters.
  • Steve Schonfeld's Verastem position peaked at $381K in Q4 2018.
  • 100 funds tracked by Wall St. Rank held Verastem as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.